Seino, Y., Rasmussen, M. F., Nishida, T., & Kaku, K. (2011). Glucagon‐like peptide‐1 analog liraglutide in combination with sulfonylurea safely improves blood glucose measures vs sulfonylurea monotherapy in Japanese patients with type 2 diabetes: Results of a 52‐week, randomized, multicenter trial. Blackwell Publishing Ltd.
Chicago Style aipamenaSeino, Yutaka, Mads Frederik Rasmussen, Tomoyuki Nishida, and Kohei Kaku. Glucagon‐like Peptide‐1 Analog Liraglutide in Combination With Sulfonylurea Safely Improves Blood Glucose Measures Vs Sulfonylurea Monotherapy in Japanese Patients With Type 2 Diabetes: Results of a 52‐week, Randomized, Multicenter Trial. Blackwell Publishing Ltd, 2011.
MLA aipamenaSeino, Yutaka, Mads Frederik Rasmussen, Tomoyuki Nishida, and Kohei Kaku. Glucagon‐like Peptide‐1 Analog Liraglutide in Combination With Sulfonylurea Safely Improves Blood Glucose Measures Vs Sulfonylurea Monotherapy in Japanese Patients With Type 2 Diabetes: Results of a 52‐week, Randomized, Multicenter Trial. Blackwell Publishing Ltd, 2011.